Skip to main content

Advertisement

SpringerLink
Log in

Novel insights into the biology of interleukin-32

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract

Interleukin (IL)-32 is known as a proinflammatory cytokine that is likely involved in several diseases, including infections, chronic inflammation, and cancer. Since the first report in 2005, IL-32 has been the subject of numerous studies to unravel the biological function of this molecule. For example, silencing of endogenous IL-32 in primary or cell lines of human origin consistently suppressed responses to Toll-like receptors. The protein folding structure of the six isoforms of IL-32 does not resemble that of any classical cytokine and as of this writing, a specific IL-32 receptor has not been identified. Instead, we propose a mechanism by which exposure to extracellular IL-32 or overexpression of the molecule results in binding to intracellular partners that influences functions such as gene expression, cell death, or survival. As such, this review offers insights into the role of IL-32 in several diseases, host defense, inflammation, immune function, and cancer. Finally, possibilities to target IL-32 in several diseases are proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Dahl CA, Schall RP, He HL, Cairns JS (1992) Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 148:597–603

    PubMed  CAS  Google Scholar 

  2. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22:131–142

    PubMed  CAS  Google Scholar 

  3. Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, Izuhara K (2006) Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 18:233–240

    Article  PubMed  CAS  Google Scholar 

  4. Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA (2011) Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci USA 108:4962–4967

    Article  PubMed  CAS  Google Scholar 

  5. Heinhuis B, Netea MG, van den Berg WB, Dinarello CA, Joosten LA (2012) Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine 60:321–327

    Article  PubMed  CAS  Google Scholar 

  6. Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA, Joosten LA (2012) IL-32 contains a typical alpha-helix bundle structure that resembles the focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem 287:5733–5743

    Article  PubMed  CAS  Google Scholar 

  7. Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SH (2008) Identification of the most active interleukin-32 isoform. Immunology 126:535–542

    Article  PubMed  Google Scholar 

  8. Hasegawa H, Thomas HJ, Schooley K, Born TL (2011) Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. Cytokine 53:74–83

    Article  PubMed  CAS  Google Scholar 

  9. Heinhuis B, Koenders MI, van Riel PL, van de Loo FA, Dinarello CA, Netea MG, van den Berg WB, Joosten LA (2010) Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis 70:660–667

    Article  PubMed  Google Scholar 

  10. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH (2005) IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102:16309–16314

    Article  PubMed  CAS  Google Scholar 

  11. Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, Kim SH, Dinarello CA (2006) Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 3:e277

    Article  PubMed  Google Scholar 

  12. Schenk M, Krutzik SR, Sieling PA, Lee DJ, Teles RM, Ochoa MT, Komisopoulou E, Sarno EN, Rea TH, Graeber TG, Kim S, Cheng G, Modlin RL (2012) NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med 18:555–563

    Article  PubMed  CAS  Google Scholar 

  13. Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello CA, Saetta M (2008) IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178:894–901

    Article  PubMed  CAS  Google Scholar 

  14. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 103:3298–3303

    Article  PubMed  CAS  Google Scholar 

  15. Kang YH, Park MY, Yoon DY, Han SR, Lee CI, Ji NY, Myung PK, Lee HG, Kim JW, Yeom YI, Jang YJ, Ahn DK, Kim JW, Song EY (2011) Dysregulation of overexpressed IL-32alpha in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-kappaB and Bcl-2. Cancer Lett 318:226–233

    Article  PubMed  Google Scholar 

  16. Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, Zhu Y (2008) Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS ONE 3:e1985

    Article  PubMed  Google Scholar 

  17. Moschen AR, Fritz T, Clouston AD, Rebhan I, Bauhofer O, Barrie HD, Powell EE, Kim SH, Dinarello CA, Bartenschlager R, Jonsson JR, Tilg H (2011) Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology 53:1819–1829

    Article  PubMed  CAS  Google Scholar 

  18. Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, Dinarello CA (2008) Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol 181:557–565

    PubMed  CAS  Google Scholar 

  19. Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, Kinoshita H, Sakamoto K, Nakagawa H, Akanuma M, Yoshida H, Maeda S, Koike K (2012) Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun 80:3795–3803

    Article  PubMed  CAS  Google Scholar 

  20. Smith AJ, Toledo CM, Wietgrefe SW, Duan L, Schacker TW, Reilly CS, Haase AT (2011) The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J Immunol 186:6576–6584

    Article  PubMed  CAS  Google Scholar 

  21. Sorrentino C, Di CE (2009) Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 180:769–779

    Article  PubMed  CAS  Google Scholar 

  22. Xu Q, Pan X, Shu X, Cao H, Li X, Zhang K, Lu J, Zou Y, Li X, Liu H, Zhang Y, Yang D, Ning Q, Shen G, Li G (2012) Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect 65:336–342

    Article  PubMed  Google Scholar 

  23. Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF (2011) Protection from RNA and DNA viruses by IL-32. J Immunol 186:4110–4118

    Article  PubMed  CAS  Google Scholar 

  24. Bae S, Kang D, Hong J, Chung B, Choi J, Jhun H, Hong K, Kim E, Jo S, Lee S, Kim SH, Kim S (2012) Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine 58:79–86

    Article  PubMed  CAS  Google Scholar 

  25. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flano E (2012) Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 86:5422–5436

    Article  PubMed  CAS  Google Scholar 

  26. Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y (2010) IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol 185:5056–5065

    Article  PubMed  CAS  Google Scholar 

  27. Bai X, Ovrutsky AR, Kartalija M, Chmura K, Kamali A, Honda JR, Oberley-Deegan RE, Dinarello CA, Crapo JD, Chang LY, Chan ED (2011) IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease. Int Immunol 23:679–691

    Article  PubMed  CAS  Google Scholar 

  28. Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA, Chan ED (2010) IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol 184:3830–3840

    Article  PubMed  CAS  Google Scholar 

  29. Bai X, Shange S, Orway D, Basaraba R, Orme IM, Ovrusky AR, Matsuda JL, Azam T, Kim S-H, Dinarello CA (2013) Mice expressing human interleukin-32 in the lungs are more resistant to Mycobacterium tuberculosis. J Am Thoras Soc (in press)

  30. Ciccia F, Rizzo A, Ccardo-Palumbo A, Giardina A, Bombardieri M, Guggino G, Taverna S, Leo GD, Alessandro R, Triolo G (2012) Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients. Rheumatology (Oxford) 51:1966–1972

    Article  CAS  Google Scholar 

  31. Kobayashi H, Yazlovitskaya EM, Lin PC (2009) Interleukin-32 positively regulates radiation-induced vascular inflammation. Int J Radiat Oncol Biol Phys 74:1573–1579

    Article  PubMed  CAS  Google Scholar 

  32. Kobayashi H, Lin PC (2009) Molecular characterization of IL-32 in human endothelial cells. Cytokine 46:351–358

    Article  PubMed  CAS  Google Scholar 

  33. Soyka MB, Treis A, Eiwegger T, Menz G, Zhang S, Holzmann D, Akdis CA, Meyer N (2012) Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy 67:790–798

    Article  PubMed  CAS  Google Scholar 

  34. Marcondes AM, Li X, Tabellini L, Bartenstein M, Kabacka J, Sale GE, Hansen JA, Dinarello CA, Deeg HJ (2011) Inhibition of IL-32 activation by alpha-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood 118:5031–5039

    Article  PubMed  CAS  Google Scholar 

  35. Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA, Deeg HJ (2008) Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci USA 105:2865–2870

    Article  PubMed  CAS  Google Scholar 

  36. Nishida A, Andoh A, Inatomi O, Fujiyama Y (2009) Interleukin-32 expression in the pancreas. J Biol Chem 284:17868–17876

    Article  PubMed  CAS  Google Scholar 

  37. Zhang F, Sha J, Wood TG, Galindo CL, Garner HR, Burkart MF, Suarez G, Sierra JC, Agar SL, Peterson JW, Chopra AK (2008) Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA). Cell Signal 20:844–861

    Article  PubMed  CAS  Google Scholar 

  38. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, Deng G, Dahiya R (2010) MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116:5637–5649

    Article  PubMed  CAS  Google Scholar 

  39. Liu S, Tetzlaff MT, Liu A, Liegl-Atzwanger B, Guo J, Xu X (2012) Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 92:1084–1096

    Article  PubMed  CAS  Google Scholar 

  40. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R (2011) MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res 71:2611–2621

    Article  PubMed  CAS  Google Scholar 

  41. Yue X, Wang P, Xu J, Zhu Y, Sun G, Pang Q, Tao R (2012) MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep 27:1200–1206

    PubMed  CAS  Google Scholar 

  42. Mabilleau G, Sabokbar A (2009) Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS ONE 4:e4173

    Article  PubMed  Google Scholar 

  43. Turner-Brannen E, Choi KY, Arsenault R, El-Gabalawy H, Napper S, Mookherjee N (2011) Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J Immunol 186:7127–7135

    Article  PubMed  CAS  Google Scholar 

  44. Jeong HJ, Han NR, Moon PD, Kim MH, Kim HM (2011) Intracellular calcium level is upregulated by interleukin-32 in auditory cells. Cytokine 53:153–157

    Article  PubMed  CAS  Google Scholar 

  45. Oh JH, Cho MC, Kim JH, Lee SY, Kim HJ, Park ES, Ban JO, Kang JW, Lee DH, Shim JH, Han SB, Moon DC, Park YH, Yu DY, Kim JM, Kim SH, Yoon DY, Hong JT (2011) IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals. Oncogene 30:3345–3359

    Article  PubMed  CAS  Google Scholar 

  46. Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH (2006) Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 103:3316–3321

    Article  PubMed  CAS  Google Scholar 

  47. Kim S, Lee S, Her E, Bae S, Choi J, Hong J, Jaekal J, Yoon D, Azam T, Dinarello CA, Kim S (2008) Proteinase 3-processed form of the recombinant IL-32 separate domain. BMB Rep 41:814–819

    Article  PubMed  CAS  Google Scholar 

  48. Cabodi S, Di SP, Leal MP, Tinnirello A, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, Defilippi P (2010) Integrins and signal transduction. Adv Exp Med Biol 674:43–54

    Article  PubMed  CAS  Google Scholar 

  49. Kinashi T (2012) Overview of integrin signaling in the immune system. Methods Mol Biol 757:261–278

    Article  PubMed  Google Scholar 

  50. Schaller MD (2004) FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration? J Cell Biol 166:157–159

    Article  PubMed  CAS  Google Scholar 

  51. Yano H, Mazaki Y, Kurokawa K, Hanks SK, Matsuda M, Sabe H (2004) Roles played by a subset of integrin signaling molecules in cadherin-based cell–cell adhesion. J Cell Biol 166:283–295

    Article  PubMed  CAS  Google Scholar 

  52. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56–68

    Article  PubMed  CAS  Google Scholar 

  53. Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K, Rhyner C, Indermitte P, Schmid-Grendelmeier P, Akdis M, Menz G, Akdis CA (2010) IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 125:858–865

    Article  PubMed  CAS  Google Scholar 

  54. Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA (2009) IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 106:3883–3888

    Article  PubMed  CAS  Google Scholar 

  55. Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J, Zhu Y (2009) Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol 39:1019–1024

    Article  PubMed  CAS  Google Scholar 

  56. Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, Mu Y, Xing HX, Wu J, Zhu Y (2008) Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett 117:161–167

    Article  PubMed  CAS  Google Scholar 

  57. Kudo M, Ogawa E, Kinose D, Haruna A, Takahashi T, Tanabe N, Marumo S, Hoshino Y, Hirai T, Sakai H, Muro S, Date H, Mishima M (2012) Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res 13:19

    Article  PubMed  CAS  Google Scholar 

  58. Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A, Fujiyama Y (2008) Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 294:G831–G838

    Article  PubMed  CAS  Google Scholar 

  59. Mun SH, Kim JW, Nah SS, Ko NY, Lee JH, Kim JD, Kim DK, Kim HS, Choi JD, Kim SH, Lee CK, Park SH, Kim BK, Kim HS, Kim YM, Choi WS (2009) Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 60:678–685

    Article  PubMed  CAS  Google Scholar 

  60. Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, Dinarello CA, Kim SH (2008) Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA 105:3515–3520

    Article  PubMed  CAS  Google Scholar 

  61. Ariel A, Serhan CN (2012) New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front Immunol 3:4

    PubMed  Google Scholar 

  62. Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B (2010) Effect of interleukin-32gamma on differentiation of osteoclasts from CD14 + monocytes. Arthritis Rheum 62:515–523

    PubMed  CAS  Google Scholar 

  63. Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC (2010) Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 5:e9458

    Article  PubMed  Google Scholar 

  64. Park MH, Song MJ, Cho MC, Moon DC, Yoon DY, Han SB, Hong JT (2012) Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3. Immunology 135:63–72

    Article  PubMed  CAS  Google Scholar 

  65. Qu Y, Taylor JL, Bose A, Storkus WJ (2011) Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32. Cancer Gene Ther 18:663–673

    Article  PubMed  CAS  Google Scholar 

  66. Jung MY, Son MH, Kim SH, Cho D, Kim TS (2011) IL-32{gamma} induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol 186:6848–6859

    Article  PubMed  CAS  Google Scholar 

  67. Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rho G, Kim S (2010) Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 49:171–176

    Article  PubMed  CAS  Google Scholar 

  68. Nold MF, Nold-Petry CA, Zepp JA, Dinkel H, Palmer BE, Farkas L, Cool CD, Taraseviciene-Stewart L, Kim S-H, Heinhuis B, Joosten LAB, Dinarello CA, Voelkel NF (2013) IL-32 promotes angiogenesis. J Immunol (in press)

  69. Cheon S, Lee JH, Park S, Bang SI, Lee WJ, Yoon DY, Yoon SS, Kim T, Min H, Cho BJ, Lee HJ, Lee KW, Jeong SH, Park H, Cho D (2011) Overexpression of IL-32{alpha} increases NK cell-mediated killing through up-regulation of Fas and ULBP2 expression in human chronic myeloid leukemia cells. J Biol Chem 286:12049–12055

    Article  PubMed  CAS  Google Scholar 

  70. Byron A, Humphries JD, Askari JA, Craig SE, Mould AP, Humphries MJ (2009) Anti-integrin monoclonal antibodies. J Cell Sci 122:4009–4011

    Article  PubMed  CAS  Google Scholar 

  71. Hao HF, Takaoka M, Bao XH, Wang ZG, Tomono Y, Sakurama K, Ohara T, Fukazawa T, Yamatsuji T, Fujiwara T, Naomoto Y (2012) Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer. Biochem Biophys Res Commun 423:744–749

    Article  PubMed  CAS  Google Scholar 

  72. Ma WW (2011) Development of focal adhesion kinase inhibitors in cancer therapy. Anticancer Agents Med Chem 11:638–642

    Article  PubMed  CAS  Google Scholar 

  73. Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinforma 9:40

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine (463), Radboud University Nijmegen Medical Centre, Geert Grooteplein zuid 8, 6525 GA, Nijmegen, The Netherlands

    Leo A. B. Joosten, Bas Heinhuis, Mihai G. Netea & Charles A. Dinarello

  2. Institute of Infection, Inflammation and Immunity (N4i), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

    Leo A. B. Joosten, Bas Heinhuis & Mihai G. Netea

  3. Department of Medicine, University of Colorado Denver, Aurora, CO, USA

    Leo A. B. Joosten & Charles A. Dinarello

Authors
  1. Leo A. B. Joosten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bas Heinhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mihai G. Netea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles A. Dinarello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leo A. B. Joosten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joosten, L.A.B., Heinhuis, B., Netea, M.G. et al. Novel insights into the biology of interleukin-32. Cell. Mol. Life Sci. 70, 3883–3892 (2013). https://doi.org/10.1007/s00018-013-1301-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-013-1301-9

Keywords

Search

Navigation